Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE

Tatsuya Konishi, Toshiki Ochi, Masaki Maruta, Kazushi Tanimoto, Yukihiro Miyazaki, Chika Iwamoto, Takashi Saitou, Takeshi Imamura, Masaki Yasukawa, Katsuto Takenaka

Blood (2023) 142 (21): 1789–1805.

https://doi.org/10.1182/blood.2022019082

Published: 2023

Includes: Supplemental data

Journal Articles

Development of a New CAR-T-Cell Therapy Targeting an Immune Checkpoint for Effective Treatment of Solid and Liquid Tumors

Toshiki Ochi, Yuko Matsuoka, Tatsuya Konishi, Masaki Maruta, Yukihiro Miyazaki, Kazushi Tanimoto, Masaki Yasukawa, Masakatsu Yamashita, Katsuto Takenaka

Blood (2023) 142 (Supplement 1): 6823.

https://doi.org/10.1182/blood-2023-177852

Published: 2023

Journal Articles

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Masaki Maruta, MD, Toshiki Ochi, MD PhD, Kazushi Tanimoto, MD PhD, Taichi Azuma, MD PhD, Hiroshi Fujiwara, MD PhD, Masaki Yasukawa, MD PhD

Blood (2017) 130 (Supplement 1): 1913.

https://doi.org/10.1182/blood.V130.Suppl_1.1913.1913

Published: 2017

Journal Articles

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Blood (2017) 130 (18): 1985–1994.

https://doi.org/10.1182/blood-2017-06-791202

Published: 2017

Includes: Supplemental data

Journal Articles

Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor

Kazushi Tanimoto, MD PhD, Hiroshi Fujiwara, MD PhD, Isao Tawara, MD PhD, Masahiro Masuya, MD PhD, Shinichi Kageyama, MD PhD, Tetsuya Nishida, MD PhD, Makoto Murata, MD PhD, Seitaro Terakura, MD PhD, Yoshiki Akatsuka, MD PhD, Hiroaki Ikeda, MD PhD, Yoshihiro Miyahara, MD PhD, Ikuei Nukaya, PhD, Kazutoh Takesako, PhD, Nobuhiko Emi, MD PhD, Naoyuki Katayama, MD PhD, Hiroshi Shiku, MD PhD, Masaki Yasukawa, MD PhD

Blood (2016) 128 (22): 1653.

https://doi.org/10.1182/blood.V128.22.1653.1653

Published: 2016

Journal Articles

Targeting Aurora Kinase with a Superior T-Cell Receptor Gene-Transfer Vector

Nicholas Casey, PhD, Hiroshi Fujiwara, MD PhD, Kazushi Tanimoto, MDPhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD PhD, Hiroshi Shiku, MD PhD, Masaki Yasukawa, MD PhD

Blood (2015) 126 (23): 4291.

https://doi.org/10.1182/blood.V126.23.4291.4291

Published: 2015

Journal Articles

A Novel Standardized Quantitative Suppression Assay Reveals a Diversity of Human Immune-Regulatory Cell Potency

Samantha Miner, Nancy F. Hensel, Bahey Salem, Neil Dunavin, MD, Kazushi Tanimoto, MD, Minoo Battiwalla, MD MS, Kit Lu, MD, Keyvan Keyvanfar, BS, Marianna Sabatino, David Stroncek, Patrick J Hanley, PhD, Catherine M. Bollard, MBChB, MD, Katayoun Rezvani, MD, PhD, Marcin Kortylewski, PhD, Pawel Muranski, MD, John Barrett, MD, Sawa Ito, MD

Blood (2014) 124 (21): 316.

https://doi.org/10.1182/blood.V124.21.316.316

Published: 2014

Journal Articles

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

Kazushi Tanimoto, MD PhD, Hiroshi Fujiwara, MD PhD, Hiroki Tanaka, MD, Fumihiro Ochi, MD, Hiroaki Asai, MDPhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD PhD, Hiroshi Shiku, MD PhD, John Barrett, MD, Masaki Yasukawa, MD PhD

Blood (2014) 124 (21): 307.

https://doi.org/10.1182/blood.V124.21.307.307

Published: 2014

Journal Articles

Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways

Samantha Miner, B.S., Sawa Ito, Kazushi Tanimoto, MD, Nancy F. Hensel, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, PhD, Pawel Muranski, MD, A. John Barrett

Blood (2013) 122 (21): 3885.

https://doi.org/10.1182/blood.V122.21.3885.3885

Published: 2013

Journal Articles

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Sawa Ito, MD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, Ph.D., Mattias Carlsten, MD Ph.D, Angelique Biancotto, PhD, Ena Wang, M.D., Zhi Xie, Ph.D., Pawel Muranski, MD, Matthew J. Olnes, MD, PhD, Kazushi Tanimoto, MD, Paula Schum, R.N., Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Thomas Hughes, Pharm D, Leodayan Bojanowski, DNP, CIP, RN, Nancy F. Hensel, BS, Neal S. Young, MD, A. John Barrett, MD

Blood (2012) 120 (21): 3283.

https://doi.org/10.1182/blood.V120.21.3283.3283

Published: 2012

Journal Articles

Abrogation of Myeloid Derived Suppressor Cell-Like Inhibitory Activity of K562 Restores Antigen Presenting Cell Functions

Kazushi Tanimoto, MD, PhD, Pawel Muranski, MD, Nancy F. Hensel, BS, Keyvan Keyvanfar, BS, Hiroshi Fujiwara, MD, PhD, A. John Barrett, MD, J. Joseph Melenhorst, PhD

Blood (2012) 120 (21): 4118.

https://doi.org/10.1182/blood.V120.21.4118.4118

Published: 2012

Journal Articles

Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+ and CD4+ Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)

Alexandros Spyridonidis, MD, Pawel Muranski, MD, Sid Kerkar, MD, Kazushi Tanimoto, MD, Nancy F. Hensel, BS, J. Joseph Melenhorst, PhD, A. John Barrett, MD

Blood (2012) 120 (21): 4121.

https://doi.org/10.1182/blood.V120.21.4121.4121

Published: 2012

Journal Articles

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Kazushi Tanimoto, MD, Yoshihiro Yakushijin, MD, PhD, Hiroshi Fujiwara, MD, PhD, Masaki Otsuka, MD, PhD, Koichi Ohshima, MD, PhD, Atsuro Sugita, MD, PhD, Akira Sakai, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2008) 112 (11): 1781.

https://doi.org/10.1182/blood.V112.11.1781.1781

Published: 2008

Journal Articles

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Teruhiko Kozuka, MD, Kazushi Tanimoto, MD, Koichi Nakase, MD, Yuichiro Nawa, MD, Masamichi Hara, MD

Blood (2006) 108 (11): 5384.

https://doi.org/10.1182/blood.V108.11.5384.5384

Published: 2006

Journal Articles

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Kazushi Tanimoto, MD, Hiroko Bessho, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, MD, PhD, Hiroshi Narumi, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2006) 108 (11): 4626.

https://doi.org/10.1182/blood.V108.11.4626.4626

Published: 2006

NARROW

Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE

Development of a New CAR-T-Cell Therapy Targeting an Immune Checkpoint for Effective Treatment of Solid and Liquid Tumors

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor

Targeting Aurora Kinase with a Superior T-Cell Receptor Gene-Transfer Vector

A Novel Standardized Quantitative Suppression Assay Reveals a Diversity of Human Immune-Regulatory Cell Potency

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Abrogation of Myeloid Derived Suppressor Cell-Like Inhibitory Activity of K562 Restores Antigen Presenting Cell Functions

Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+ and CD4+ Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only